Controlled ovarian stimulation with recombinant follicle-stimulating hormone provides better outcomes than urinary gonadotropins for patients undergoing assisted reproductive technologies.

✍ Scribed by M.D Scheiber; E.J Behnke; S.G Awadalla

• Book ID: 119418002
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 25 KB
• Volume: 76
• Category: Article
• ISSN: 1556-5653
• DOI: 10.1016/s0015-0282(01)02699-1